|
|---|
|
Tseng WW,
Barretta F,
Conti L,
Grignani G,
Tolomeo F,
Albertsmeier M,
Angele MK,
Rutkowski P,
Skoczylas J,
De Paoli A,
Navarria F,
Raut CP,
Fairweather M,
Farma JM,
Nessim C,
Goel N,
Grignol VP,
Ford SJ,
Cardona K,
Subhawong T,
Tattersall HL,
Lee RM,
Hu JS,
von Mehren M,
Sanfilippo R,
Gronchi A. Defining the role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma: A multi-institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group.
Cancer. 2021 Mar 1;127(5)
:729-738. |
|
Harounian JA,
Molin N,
Galloway TJ,
Ridge D,
Bauman J,
Farma J,
Reddy S,
Lango MN. Effect of Sentinel Lymph Node Biopsy and LVI on Merkel Cell Carcinoma Prognosis and Treatment.
Laryngoscope. 2021 Mar;131(3)
:E828-E835. |
|
Gauvin G,
Do-Nguyen CC,
Lou J,
O'Halloran EA,
Selesner LT,
Handorf E,
Collins ME,
Farma JM. Gastrostomy Tube for Nutrition and Malignant Bowel Obstruction in Patients With Cancer.
J Natl Compr Canc Netw. 2021 Jan 6;19(1)
:48-56. |
|
Moslim MA,
Minarich MJ,
Deng M,
Handorf E,
Greco SH,
Reddy SS,
Farma JM. Treatment at an Academic Cancer Center Confers Better Survival by Stage for Signet-Ring Cell and Non-signet-Ring Cell Gastric Cancer.
Ann Surg Oncol. 2021 Jan 3
. |
|
Hill MV,
Bleicher RJ,
Farma JM. A How-To Guide: Virtual Interviews in the Era of Social Distancing.
J Surg Educ. 2021 Jan-Feb;78(1)
:321-323. PMC ID:PMC7391954. |
|
Ward WH,
Meeker CR,
Handorf E,
Hill MV,
Einarson M,
Alpaugh RK,
Holden TL,
Astsaturov I,
Denlinger CS,
Hall MJ,
Reddy SS,
Sigurdson ER,
Dotan E,
Zibelman M,
Meyer JE,
Farma JM,
Vijayvergia N. Feasibility of Fitness Tracker Usage to Assess Activity Level and Toxicities in Patients With Colorectal Cancer.
JCO Clin Cancer Inform. 2021 Jan;5
:125-133. |
|
Carr MJ,
Sun J,
Kroon HM,
Miura JT,
Beasley GM,
Farrow NE,
Mosca PJ,
Lowe MC,
Farley CR,
Kim Y,
Naqvi SMH,
Kirichenko DA,
Potdar A,
Daou H,
Mullen D,
Farma JM,
Henderson MA,
Speakman D,
Serpell J,
Delman KA,
Smithers BM,
Coventry BJ,
Tyler DS,
Thompson JF,
Zager JS. Oncologic Outcomes After Isolated Limb Infusion for Advanced Melanoma: An International Comparison of the Procedure and Outcomes Between the United States and Australia.
Ann Surg Oncol. 2020 Dec;27(13)
:5107-5118. PMC ID:PMC7674259. |
|
Moten AS,
von Mehren M,
Reddy S,
Howell K,
Handorf E,
Farma JM. Treatment Patterns and Distance to Treatment Facility for Soft Tissue Sarcoma of the Extremity.
J Surg Res. 2020 Dec;256
:492-501. |
|
Hill MV,
Ross EA,
Crawford D,
Lai L,
Turaga K,
Grubbs EG,
Mullen J,
Dineen S,
D'Angelica M,
Reddy S,
Farma JM. Program and candidate experience with virtual interviews for the 2020 Complex General Surgical Oncology interview season during the COVID pandemic.
Am J Surg. 2020 Nov 9
. |
|
Kenyon-Smith TJ,
Kroon HM,
Miura JT,
Teras J,
Beasley GM,
Mullen D,
Farrow NE,
Mosca PJ,
Lowe MC,
Farley CR,
Potdar A,
Daou H,
Sun J,
Farma JM,
Henderson MA,
Speakman D,
Serpell J,
Delman KA,
Smithers BM,
Barbour A,
Coventry BJ,
Tyler DS,
Zager JS,
Thompson JF. Factors predicting toxicity and response following isolated limb infusion for melanoma: An international multi-centre study.
Eur J Surg Oncol. 2020 Nov;46(11)
:2140-2146. |
|
Loo K,
Gauvin G,
Soliman I,
Renzetti M,
Deng M,
Ross E,
Luo B,
Wu H,
Reddy S,
Olszanski AJ,
Farma JM. Primary tumor characteristics and next-generation sequencing mutations as biomarkers for melanoma immunotherapy response.
Pigment Cell Melanoma Res. 2020 Nov;33(6)
:878-888. PMC ID:PMC7713701. |
|
Iyer P,
Moslim M,
Farma JM,
Denlinger CS. Diffuse gastric cancer: Histologic, molecular, and genetic basis of disease.
Translational Gastroenterology and Hepatology. 2020 Oct;5
:52. PMC ID:PMC7530323. |
|
Loo K,
Soliman I,
Renzetti M,
Li T,
Wu H,
Reddy S,
Olszanski AJ,
Farma JM. Impact of Sun Exposure and Tanning Patterns on Next-Generation Sequencing Mutations in Melanoma.
J Surg Res. 2020 Oct;254
:147-153. |
|
McGillivray E,
Farma J,
Savage M,
Hall MJ,
Luo B,
Jain R. Pathologic Complete Response in Patient With ATM Mutation After Neoadjuvant FOLFOXIRI Plus Panitumumab Therapy for Locally Advanced Colon Cancer: A Case Report.
Clin Colorectal Cancer. 2020 Sep 18
. |
|
In GK,
Poorman K,
Saul M,
O'Day S,
Farma JM,
Olszanski AJ,
Gordon MS,
Thomas JS,
Eisenberg B,
Flaherty L,
Weise A,
Daveluy S,
Gibney G,
Atkins MB,
Vanderwalde A. Molecular profiling of melanoma brain metastases compared to primary cutaneous melanoma and to extracranial metastases.
Oncotarget. 2020 Aug 18;11(33)
:3118-3128. PMC ID:PMC7443369. |
|
Hill MV,
Bleicher RJ,
Farma JM. A How-To Guide: Virtual Interviews in the Era of Social Distancing.
J Surg Educ. 2020 Jul 30
. PMC ID:PMC7391954. |
|
Wong JK,
Handorf E,
Lee D,
Jain R,
Zhang E,
Cooper HS,
Farma JM,
Dotan E,
Meyer JE. Toxicity and outcomes in older versus younger patients treated with trimodality therapy for locally advanced rectal cancer.
J Geriatr Oncol. 2020 May 4;11(8)
:1331-1334. PMC ID:PMC7606716. |
|
Teras J,
Kroon HM,
Miura JT,
Kenyon-Smith T,
Beasley GM,
Mullen D,
Farrow NE,
Mosca PJ,
Lowe MC,
Farley CR,
Potdar A,
Daou H,
Sun J,
Carr M,
Farma JM,
Henderson MA,
Speakman D,
Serpell J,
Delman KA,
Smithers BM,
Barbour A,
Tyler DS,
Coventry BJ,
Zager JS,
Thompson JF. International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients.
Ann Surg Oncol. 2020 May;27(5)
:1420-1429. |
|
Ebersole B,
Lango M,
Ridge J,
Handorf E,
Farma J,
Clark S,
Jamal N. Dysphagia Screening for Pneumonia Prevention in a Cancer Hospital: Results of a Quality/Safety Initiative.
Otolaryngol Head Neck Surg. 2020 Feb;162(2)
:220-229. PMC ID:PMC7723302. |
|
Lou J,
Moten AS,
Reddy SS,
Howell KJ,
Movva S,
von Mehren M,
Farma JM. Retroperitoneal Sarcomas: Does Laterality Matter?.
J Surg Res. 2019 Dec;244
:34-41. PMC ID:PMC6815680. |
|
Sorenson E,
Lambreton F,
Yu JQ,
Li T,
Denlinger CS,
Meyer JE,
Sigurdson ER,
Farma JM. Impact of PET/CT for Restaging Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation.
J Surg Res. 2019 Nov;243
:242-248. |
|
Miura JT,
Kroon HM,
Beasley GM,
Mullen D,
Farrow NE,
Mosca PJ,
Lowe MC,
Farley CR,
Kim Y,
Naqvi SMH,
Potdar A,
Daou H,
Sun J,
Farma JM,
Henderson MA,
Speakman D,
Serpell J,
Delman KA,
Mark Smithers B,
Coventry BJ,
Tyler DS,
Thompson JF,
Zager JS. Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis.
Ann Surg Oncol. 2019 Aug;26(8)
:2486-2494. |
|
Hanada Y,
Choi AY,
Hwang JH,
Draganov PV,
Khanna L,
Sethi A,
Bartel MJ,
Goel N,
Abe S,
De Latour RA,
Park K,
Melis M,
Newman E,
Hatzaras I,
Reddy SS,
Farma JM,
Liu X,
Schlachterman A,
Kresak J,
Trapp G,
Ansari N,
Schrope B,
Lee JY,
Dhall D,
Lo S,
Jamil LH,
Burch M,
Gaddam S,
Gong Y,
Del Portillo A,
Tomizawa Y,
Truong CD,
Brewer Gutierrez OI,
Montgomery E,
Johnston FM,
Duncan M,
Canto M,
Ahuja N,
Lennon AM,
Ngamruengphong S. Low Frequency of Lymph Node Metastases in Patients in the United States With Early-stage Gastric Cancers That Fulfill Japanese Endoscopic Resection Criteria.
Clin Gastroenterol Hepatol. 2019 Aug;17(9)
:1763-1769. |
|
Moten AS,
Zhao H,
Howell K,
Nadler A,
Reddy SS,
von Mehren M,
Movva S,
Farma JM. Soft tissue sarcoma of the extremity: Characterizing symptom duration and outcomes.
Surg Oncol. 2019 Jun;29
:190-195. |
|
Goel N,
Manstein SM,
Ward WH,
DeMora L,
Smaldone MC,
Farma JM,
Uzzo RG,
Esnaola NF. Does the Surgical Apgar Score predict serious complications after elective major cancer surgery?.
J Surg Res. 2018 Nov;231
:242-247. |
|
Moten AS,
Zhao H,
Wu H,
Farma JM. Malignant granular cell tumor: Clinical features and long-term survival.
J Surg Oncol. 2018 Nov ;118(6)
:891-897. |
|
Moten AS,
Movva S,
von Mehren M,
Wu H,
Esnaola NF,
Reddy SS,
Farma JM. Granular cell tumor experience at a comprehensive cancer center.
J Surg Res. 2018 Jun;226
:1-7. |
|
Bichakjian CK,
Olencki T,
Aasi SZ,
Alam M,
Andersen JS,
Blitzblau R,
Bowen GM,
Contreras CM,
Daniels GA,
Decker R,
Farma JM,
Fisher K,
Gastman B,
Ghosh K,
Grekin RC,
Grossman K,
Ho AL,
Lewis KD,
Loss M,
Lydiatt DD,
Messina J,
Nehal KS,
Nghiem P,
Puzanov I,
Schmults CD,
Shaha AR,
Thomas V,
Xu YG,
Zic JA,
Hoffmann KG,
Engh AM. Merkel Cell Carcinoma, Version 1.2018 Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network. 2018 Jun;16(6)
:742-774. |
|
Goetz A,
Nweze N,
Joshi A,
Farma J. Synchronous subcutaneous granular cell tumours, a rare presentation.
Ann R Coll Surg Engl. 2018 Apr;100(4)
:e1-e3. PMC ID:PMC5958858. |
|
Ward WH,
Sigurdson ER,
Esposito AC,
Ruth KJ,
Manstein SM,
Sorenson EC,
Wernick BD,
Farma JM. Pathologic response following treatment for locally advanced rectal cancer: Does location matter?.
J Surg Res. 2018 April;224
:215-221. PMC ID:PMC7811804. |
|
Ward WH,
Goel N,
Ruth KJ,
Esposito AC,
Lambreton F,
Sigurdson ER,
Meyer JE,
Farma JM. Predictive value of leukocyte- and platelet-derived ratios in rectal adenocarcinoma.
J Surg Res. 2018 December;232
:275-282. |
|
Nitzkorski JR,
Willis AI,
Nick D,
Zhu F,
Farma JM,
Sigurdson ER. In Reply: Vitamin D Status May Explain Some of the Racial Disparities in Rectal Cancer.
Ann Surg Oncol. 2017 Dec;24(Suppl 3)
:597. |
|
Finnberg NK,
Gokare P,
Lev A,
Grivennikov SI,
MacFarlane AW,
Campbell KS,
Winters RM,
Kaputa K,
Farma JM,
Abbas AE,
Grasso L,
Nicolaides NC,
El-Deiry WS. Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signatures.
Oncotarget. 2017 Sep;8(40)
:66747-66757. PMC ID:PMC5620133. |
|
Zendejas B,
Jakub JW,
Terando AM,
Sarnaik A,
Ariyan CE,
Faries MB,
Zani S Jr,
Neuman HB,
Wasif N,
Farma JM,
Averbook BJ,
Bilimoria KY,
Tyler D,
Brady MS,
Farley DR. Laparoscopic skill assessment of practicing surgeons prior to enrollment in a surgical trial of a new laparoscopic procedure.
Surg Endosc. 2017 Aug;31(8)
:3313-3319. PMC ID:PMC6201269. |
|
Faries MB,
Thompson JF,
Cochran AJ,
Andtbacka RH,
Mozzillo N,
Zager JS,
Jahkola T,
Bowles TL,
Testori A,
Beitsch PD,
Hoekstra HJ,
Moncrieff M,
Ingvar C,
Wouters Mwjm,
Sabel MS,
Levine EA,
Agnese D,
Henderson M,
Dummer R,
Rossi CR,
Neves RI,
Trocha SD,
Wright F,
Byrd DR,
Matter M,
Hsueh E,
MacKenzie-Ross A,
Johnson DB,
Terheyden P,
Berger AC,
Huston TL,
Wayne JD,
Smithers BM,
Neuman HB,
Schneebaum S,
Gershenwald JE,
Ariyan CE,
Desai DC,
Jacobs L,
McMasters KM,
Gesierich A,
Hersey P,
Bines SD,
Kane JM,
Barth RJ,
McKinnon G,
Farma JM,
Schultz E,
Vidal-Sicart S,
Hoefer RA,
Lewis JM,
Scheri R,
Kelley MC,
Nieweg OE,
Noyes RD,
Hoon DSB,
Wang HJ,
Elashoff DA,
Elashoff RM. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.
N Engl J Med. 2017 Jun 08;376(23)
:2211-2222. PMC ID:PMC5548388. |
|
Reddy SS,
Handorf B,
Farma JM,
Sigurdson ER. Trends with neoadjuvant radiotherapy and clinical staging for those with rectal malignancies.
World J Gastrointest Surg. 2017 Apr 27;9(4)
:97-102. PMC ID:PMC5406733. |
|
Mullinax JE,
Kroon HM,
Thompson JF,
Nath N,
Mosca PJ,
Farma JM,
Bhati R,
Hardmann D,
Sileno S,
O'Donoghue C,
Perez M,
Naqvi SM,
Chen YA,
Gonzalez RJ,
Zager JS. Isolated Limb Infusion as a Limb Salvage Strategy for Locally Advanced Extremity Sarcoma.
J Am Coll Surg. 2017 Apr;224(4)
:635-642. PMC ID:PMC7771304. |
|
Jakub JW,
Terando AM,
Sarnaik A,
Ariyan CE,
Faries MB,
Zani S Jr,
Neuman HB,
Wasif N,
Farma JM,
Averbook BJ,
Bilimoria KY,
Grotz TE,
Allred JB,
Suman VJ,
Brady MS,
Tyler D,
Wayne JD,
Nelson H. Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma (SAFE-MILND): Report of a Prospective Multi-institutional Trial.
Ann Surg. 2017 Jan;265(1)
:192-196. PMC ID:PMC4999343. |
|
Porpiglia AS,
Farma JM. Current Treatment of Sarcomas.
Surg Clin North Am. 2016 Oct;96(5)
:xv-xvi. |
|
Porpiglia AS,
Reddy SS,
Farma JM. Retroperitoneal Sarcomas.
Surg Clin North Am. 2016 Oct;96(5)
:993-1001. |
|
Jakub JW,
Terando AM,
Sarnaik A,
Ariyan CE,
Faries MB,
Zani S Jr,
Neuman HB,
Wasif N,
Farma JM,
Averbook BJ,
Bilimoria KY,
Allred JB,
Suman VJ,
Grotz TE,
Zendejas B,
Wayne JD,
Tyler DS. Training High-Volume Melanoma Surgeons to Perform a Novel Minimally Invasive Inguinal Lymphadenectomy: Report of a Prospective Multi-Institutional Trial.
J Am Coll Surg. 2016 Mar;222(3)
:253-260. PMC ID:PMC5012184. |
|
Farma JM,
Kulkarni N,
Hsu C. Surgical management of primary and recurrent melanoma.
Surg Oncol Clin N Am. 2015 Apr;24(2)
:239-47. |
|
Yeo H,
Niland J,
Milne D,
ter Veer A,
Bekaii-Saab T,
Farma JM,
Lai L,
Skibber JM,
Small W Jr,
Wilkinson N,
Schrag D,
Weiser MR. Incidence of minimally invasive colorectal cancer surgery at national comprehensive cancer network centers.
J Natl Cancer Inst. 2015 Jan;107(1)
:362. PMC ID:PMC4296195. |
|
Schatz TP,
Nassif MO,
Farma JM. Extensive portal venous gas: Unlikely etiology and outcome.
J Cancer Epidemiol. 2014 Dec 11;8c
:134-136. |
|
Singla S,
Papavasiliou P,
Powers B,
Gaughan J,
von Mehren M,
Watson JC,
Farma JM. Challenges in the treatment of angiosarcoma: a single institution experience.
Am J Surg. 2014 Aug;208(2)
:254-9. |
|
Johnson ME,
Zhu F,
Li T,
Wu H,
Galloway TJ,
Farma JM,
Perlis CS,
Turaka A. Absolute lymphocyte count: a potential prognostic factor for Merkel cell carcinoma.
J Am Acad Dermatol. 2014 Jun;70(6)
:1028-35. |
|
Chen KT,
Papavasiliou P,
Edwards K,
Zhu F,
Perlis C,
Wu H,
Turaka A,
Berger A,
Farma JM. A better prognosis for Merkel cell carcinoma of unknown primary origin.
American Journal of Surgery. 2013 Nov;206(5)
:752-757. |
|
Ray M,
Farma JM,
Hsu C. Translational Research in Melanoma.
Surgical Oncology Clinics of North America. 2013 Oct;22(4)
:785-+. |
|
Arrangoiz R,
Papavasiliou P,
Singla S,
Siripurapu V,
Li T,
Watson JC,
Hoffman JP,
Farma JM. Partial stomach-partitioning gastrojejunostomy and the success of this procedure in terms of palliation.
Am J Surg. 2013 Sep;206(3)
:333-9. |
|
Farma JM,
Zager JS,
Barnica-elvir V,
Puleo CA,
Marzban SS,
Rollison DE,
Messina JL,
Sondak VK. A Collision of Diseases: Chronic Lymphocytic Leukemia Discovered During Lymph Node Biopsy for Melanoma.
Annals of Surgical Oncology. 2013 Apr;20(4)
:1360-1364. |
|
Johnson ME,
Turaka A,
Zhu F,
Galloway T,
Farma J,
Perlis C. Absolute lymphocyte count: a novel prognostic factor for merkel cell carcinoma.
Pract Radiat Oncol. 2013 Apr-Jun;3(2 Suppl 1)
:S10-1. |
|
Nitzkorski JR,
Willis AI,
Nick D,
Zhu F,
Farma JM,
Sigurdson ER. Association of Race and Socioeconomic Status and Outcomes of Patients with Rectal Cancer.
Annals of Surgical Oncology. 2013 Apr;20(4)
:1142-1147. |
|
Shanmugan S,
Arrangoiz R,
Nitzkorski JR,
Yu JQ,
Li TY,
Cooper H,
Konski A,
Farma JM,
Sigurdson ER. Predicting Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Using (18)FDG-PET/CT.
Annals of Surgical Oncology. 2012 Jul;19(7)
:2178-2185. |
|
Nitzkorski JR,
Farma JM,
Watson JC,
Siripurapu V,
Zhu F,
Matteotti RS,
Sigurdson ER. Outcome and Natural History of Patients with Stage IV Colorectal Cancer Receiving Chemotherapy Without Primary Tumor Resection.
Annals of Surgical Oncology. 2012 Feb;19(2)
:379-383. |
|
Chen KT,
Olszanski A,
Farma JM. Donor transmission of melanoma following renal transplant.
Case Rep Transplant. 2012 ;2012
:764019. PMC ID:PMC3504199. |
|
Arrangoiz R,
Papavasiliou P,
Stransky CA,
Yu JQ,
Tianyu L,
Sigurdson ER,
Berger AC,
Farma JM. Preoperative FDG-PET/CT Is an Important Tool in the Management of Patients with Thick (T4) Melanoma.
Dermatol Res Pract. 2012 ;2012
:614349. PMC ID:PMC3359680. |
|
Hernandez JM,
Farma JM,
Coppola D,
Hakam A,
Fulp WJ,
Chen DT,
Siegel EM,
Yeatman TJ,
Shibata D. Expression of the Antiapoptotic Protein Survivin in Colon Cancer.
Clinical Colorectal Cancer. 2011 Sep;10(3)
:188-193. |
|
Arrangoiz R,
Papavasiliou P,
Dushkin H,
Farma JM. Case report and literature review: Metastatic lobular carcinoma of the breast an unusual presentation.
Int J Surg Case Rep. 2011 ;2(8)
:301-5. PMC ID:PMC3215247. |
|
Farma JM,
Ammori JB,
Zager JS,
Marzban SS,
Bui MM,
Bichakjian CK,
Johnson TM,
Lowe L,
Sabel MS,
Wong SL,
Letson GD,
Messina JL,
Cimmino VM,
Sondak VK. Dermatofibrosarcoma Protuberans: How Wide Should We Resect?.
Annals of Surgical Oncology. 2010 Aug;17(8)
:2112-2118. |
|
Farma JM,
Hoffman JP. Nonneoplastic celiac axis occlusion in patients undergoing pancreaticoduodenectomy.
American Journal of Surgery. 2007 Mar;193(3)
:341-344. |
|
Berger AC,
Farma J,
Scott WJ,
Freedman G,
Weiner L,
Cheng JD,
Wang H,
Goldberg M. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival.
Journal of Clinical Oncology. 2005 Jul 1;23(19)
:4330-4337. |
|
Goldberg M,
Farma J,
Lampert C,
Colarusso P,
Coia L,
Frucht H,
Goosenberg E,
Beard M,
Weiner LM. Survival following intensive preoperative combined modality therapy with paclitaxel, cisplatin, 5-fluorouracil, and radiation in resectable esophageal carcinoma: A phase I report.
Journal of Thoracic and Cardiovascular Surgery. 2003 Oct;126(4)
:1168-1173. |
|
Faculty
Publications
